## 

## 

||||||||Page|
|---|---|---|---|---|---|---|---|
|Trustees'|annual report||(incorporating|the|director's report)||1-4|
|Independent<br>examiner's|||report to the|trustees||||
|Statement|offinancial||activities (including||income and expenditure|account)|6|
|Statement|offinancial||position|||||
|Notes to|the financial|statements|||||9-20|





## 

## 

## 

## 

## 

|Registered||charity name|charity name|Peninsula<br>Medical Foundation|Peninsula<br>Medical Foundation||||||
|---|---|---|---|---|---|---|---|---|---|---|
|Charity registration|||number|1060423|||||||
|Company|registration||number|03300591|||||||
|Principal|office and registered|||Metherell<br>Gard|||||||
|office||||Old Memorial|Hall||||||
|||||Morval|||||||
|||||Looe|||||||
|||||Comwall|||||||
|||||PL13 1PN|||||||
|The trustees|||||||||||
|||||Mr D C Wilkins|||||||
|||||MrJBKitsonDL||(Resigned||15November||2022)|
|||||Mr H Anderson||(Resigned||27 September||2022)|
|||||Mr NBBuckland|||||||
|||||ProfJA Copplestone|||||||
|||||Ms RJames|||||||
|||||Mr P McArdle|||||||
|||||Mr RH GMichelmore|||||||
|||||Mr M Plant|||||||
|||||Mr P Vosper|||||||
|||||Prof CTLewis OBE|||||||
|||||ProfH Khalil|||||||
|||||Mr6Beak||(Appointed||23 September||2022)|
|Independent||examiner||Guy Ian Northcott FCA DChA||Northcott|Trumfield||Chartered||
|||||Accountants|||||||
|||||Devonshire<br>Villa|||||||
|||||52 Stuart Road|||||||
|||||Stoke|||||||
|||||Plymouth|||||||
|||||PL3 4EE|||||||





## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 



## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

||||||||Year to|
|---|---|---|---|---|---|---|---|
|||||Period from 1Feb 22 to 31||Dec 22|31Jan 22|
|||||Unrestricted|Restricted|||
|||||funds|funds|Total funds|Total find|
||||Note|||||
|Income and endowments||||||||
|Donations<br>and legacies||||66,289||66,289|459,277|
|Other trading activities||||18,346||18,346||
|Investment<br>income||||4,360||4,360|4,431|
|Total income||||88,995||88,995|463,708|
|Expenditure||||||||
|Expenditure<br>on raising funds:||||||||
|Costs ofraising donations||and||||||
|legacies|||8|8,419||8,419|1,256|
|Investment<br>management||costs|9|1,658||1,658|2,023|
|Expenditure<br>on charitable|activities||10,11|91,422||91,422|203,695|
|Total expenditure||||101,499||101,499|206,974|
|Net (losses)/gains<br>on investments|||14|(12,254)||(12,254)|15,099|
|Net (expenditure)/income||||(24,758)||(24,758)|271,833|
|Transfers<br>between<br>funds||||2,923|(2,923)|||
|Net movement<br>in funds||||(21,835)|(2,923)|(24,758)|271,833|
|Reconciliation offunds||||||||
|Total funds brought<br>forward|||24|439,911|44,510|484,421|212,588|
|Total funds carried forward|||24|418,076|41,587|459,663|484,421|





## 

## 

## 

## 

||||||31Dec 22|31Jan 22|
|---|---|---|---|---|---|---|
|||||Note|||
|Fixed assets|||||||
|Tangible fixed assets||||19|355|474|
|Investments||||20|297,097|206,933|
||||||297,452|207,407|
|Current<br>assets|||||||
|Stocks||||21|1,800||
|Debtors||||22|3,526|427,116|
|Cash at bank|and in|hand|||234,487|34,064|
||||||239,813|461,180|
|Creditors: amounts||falling due within one year||23|77,602|184,166|
|Net current|assets||||162,211|277,014|
|Total assets|less current||liabilities||459,663|484,421|
|Net assets|||||459,663|484,421|
|Funds ofthe|charity||||||
|Restricted funds|||||41,587|44,510|
|Unrestricted|funds:||||||
|Revaluation<br>reserve|||||21,275|34,362|
|Other unrestricted|||income funds||396,801|405,549|
|Total unrestricted||funds|||418,076|439,911|
|Total charity|funds|||24|459,663|484,421|



## 



## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

## 

## 

## 



## 

## 

## 

## 

## 

## 

## 

## 

|Donations<br>and legacies|||||
|---|---|---|---|---|
|||Unrestricted|Restricted|Total Funds|
|||Funds|Funds|2022|
|Donations|||||
|Donations||20,441||20,441|
|Gift Aid received||3,100||3,100|
|Legacies|||||
|The Elwyn Thomas Memorial|Fund|42,748||42,748|
|Mrs JA Gibbs|||||
|||66,289||66,289|
|||Unrestricted|Restricted|Total Funds|
|||Funds|Funds|2022|
|Donations|||||
|Donations||20,223|8,838|29,061|
|Gift Aid received||6,006||6,006|
|Legacies|||||
|The Elwyn Thomas Memorial|Fund|375,877||375,877|
|Mrs JA Gibbs||48,333||48,333|
|||450,439|8,838|459,277|





## 

## 

|Per|iod from 1Fe|iod from 1Fe|bruary<br>2|022 to 31De|cember 2022||||
|---|---|---|---|---|---|---|---|---|
|6.|Other trading||activities||||||
||||||Unrestricted|Total Funds|Unrestricted|Total Funds|
||||||Funds|2022|Funds|2022|
||Fundraising|events|||18,346|18,346|||
|7.|Investment|income|||||||
||||||Unrestricted|Total Funds|Unrestricted|Total Funds|
||||||Funds|2022|Funds|2022|
||Income from|listed investments|||4,077|4,077|4,431|4,431|
||Bank interest|receivable|||283|283|||
||||||4,360|4,360|4,431|4,431|
|8.|Costs ofraising||donations|and legacies|||||



|||||Unrestricted|Total Funds|Unrestricted|Total Funds|
|---|---|---|---|---|---|---|---|
|||||Funds|2022|Funds|2022|
||Costs ofraising donations|||7,500|7,500|||
||Xmas cards|||2,008|2,008|||
||Closing stock|||(1,800)|(1,800)|||
||Just giving|fees||198|198|216|216|
||Advertising|||513|513|1,040|1,040|
|||||8,419|8,419|1,256|1,256|
|9.|Investment|management|costs|||||
|||||Unrestricted|Total Funds|Unrestricted|Total Funds|
|||||Funds|2022|Funds|2022|
||Portfolio management|||1,658|1,658|2,023|2,023|





## 

## 

## 

## 

||||||Unrestricted|Restricted|Total Funds|
|---|---|---|---|---|---|---|---|
||||||Funds|Funds|2022|
|Research|Grants,|Bursaries|and|Prizes|75,342||75,342|
|Medical|research|equipment||||||
|Support|costs||||16,080||16,080|
||||||91,422||91,422|
||||||Unrestricted|Restricted|Total Funds|
||||||Funds|Funds|2022|
|Research|Grants,|Bursaries|and|Prizes|7,701|9,819|17,520|
|Medical|research|equipment|||182,582||182,582|
|Support|costs||||3,593||3,593|
||||||193,876|9,819|203,695|



## 

|Expendit|ure<br>on|charitable|act|ivities by|activity type||||
|---|---|---|---|---|---|---|---|---|
||||||Activities||||
||||||undertaken||Total funds|Total fund|
||||||directly|Support costs|2022|2022|
|Research|Grants,|Bursaries|and|Prizes||16,080|16,080|21,113|
|Medical|research|equipment|||75,342||75,342|182,582|
||||||75,342|16,080|91,422|203,695|



## 

|Analysis ofsupport costs||||
|---|---|---|---|
||Analysis of|||
||support costs|Total 2022|Total 2022|
|Staff costs|7,251|7,251||
|General office|420|420|270|
|Insurance|1,022|1,022||
|Accounts|4,621|4,621|2,464|
|Administration|2,647|2,647|702|
|Depreciation|119|119|158|
||16,080|16,080|3,594|





## 

## 

## 

## 

|Peri|od from 1|February|2022|to 31D|ece|mber 2022|||||
|---|---|---|---|---|---|---|---|---|---|---|
|13.|Analysis of|grants|||||||||
|||||||||Period from|||
||||||||||1Feb 22 to|Year to|
||||||||||31Dec 22|31Jan 22|
||Grants to institutions||||||||||
||Research Grants||||||||75,342|11,890|
||Grants to individuals||||||||||
||Bursaries and Prizes|||||||||1,000|
||Brain Tumour Research|||||||||4,629|
|||||||||||5,629|
||Total grants||||||||75,342|17,519|
|14.|Net (losses)/gains<br>on investments||||||||||
|||||||Unrestricted|Total Funds|Unrestricted||Total Funds|
|||||||Funds|2022||Funds|2022|
||Gains/(losses)|on listed investments||||(12,254)|(12,254)||15,099|15,099|
|15.|Net (expenditure)/income||||||||||
||Net (expenditure)/income||is stated after charging/(crediting):||||||||
||||||||||31Dec 22|31Jan 22|
||Depreciation|oftangible fixed assets|||||||119|158|
|16.|Independent|examination|fees||||||||
|||||||||Period from|||
||||||||||1Feb 22 to|Year to|
||||||||||31Dec 22|31Jan 22|
||Fees payable|to the independent||examiner for:|||||||
||Independent|examination|ofthe|financial|statements||||1,742|1,584|
|17.|Staff costs||||||||||
||The total staff costs and employee benefits for|||||the reporting|period are analysed||as follows:||
|||||||||Period from|||
||||||||||1Feb 22 to|Year to|
||||||||||31Dec 22|31Jan 22|
||Wages and salaries||||||||7,251||





## 

## 

## 

## 

## 

## 

|Tangible Gxed assets||
|---|---|
||Equipment|
|Cost||
|At 1February 2022 and 31December 2022|879|
|Depreciation||
|At 1February 2022|405|
|Charge for the period|119|
|At 31December 2022|524|
|Carrying<br>amount||
|At 31December 2022|355|
|At 31 January 2022|474|



## 

||Cash or cash|Listed||
|---|---|---|---|
||equivalents|investments|Total|
|Cost or valuation||||
|At 1February 2022|6,440|200,493|206,933|
|Additions|19,393|95,015|114,408|
|Disposals||(11,990)|(11,990)|
|Fair value movements||(12,304)|(12,304)|
|Transfers||50|50|
|At 31December 2022|25,833|271,264|297,097|
|Impairment||||
|At 1February 2022 and 31December 2022||||
|Carrying<br>amount||||
|At 31December 2022|25,833|271,264|297,097|
|At 31January 2022|6,440|200,493|206,933|





## 

## 

|Peri|od from 1|February<br>2022 to 31December 2022|February<br>2022 to 31December 2022|||
|---|---|---|---|---|---|
|20.|InVeStmentS|(continued)||||
||All investments||shown above are held at valuation.|||
||Financial assets held at fair value|||||
||All investments||shown above are held at valuation.|||
|21.|Stocks|||||
|||||31Dec 22|31Jan 22|
||Raw materials||and consumables|1,800||
|22.|Debtors|||||
|||||31Dec 22|31Jan 22|
||Prepayments|and accrued income|||424,210|
||Other debtors|||3,526|2,906|
|||||3,526|427,116|
|23.|Creditors: amounts<br>falling due within one year|||||
|||||31Dec 22|31Jan 22|
||Accruals and|deferred income||77,085|184,166|
||Social security||and other taxes|517||
|||||77,602|184,166|





## 

## 

## 

## 

|Unrestricted|funds|||||||
|---|---|---|---|---|---|---|---|
|||At||||Gains and|At|
|||1Feb 2022|Income|Expenditure|Transfers|losses|31Dec 2022|
|General funds||330,549|88,995|(26,156)|(145,033)|(12,254)|236,101|
|Revaluation|reserve|34,362|||(13,087)||21,275|
|Designated Fund-||||||||
|Postgraduate||||||||
|Research||75,000||(75,343)|343|||
|Designated Fund-||||||||
|Microplastics||||||||
|Biobank|||||160,700||160,700|
|||439,911|88,995|(101,499)|2,923|(12,254)|418,076|
|||At||||Gains and|At|
|||1Feb 2021|Income|Expenditure|Transfers|losses|31Jan 2022|
|General funds||145,367|454,870|(197,155)|(87,632)|15,099|330,549|
|Revaluation|reserve|21,730|||12,632||34,362|
|Designated Fund-||||||||
|Postgraduate||||||||
|Research|||||75,000||75,000|
|Designated Fund-||||||||
|Microplastics||||||||
|Biobank||||||||
|||167,097|454,870|(197,155)||15,099|439,911|





## 

## 

|Restricted funds|||||||
|---|---|---|---|---|---|---|
||At||||Gains and|At|
||1Feb 2022|Income|Expenditure|Transfers|losses|31Dec 2022|
|Just Giving Zl,048|||||||
|and Vospers 62,600|3,648|||(3,648)|||
|Brain Tumour|||||||
|Research||||3,648||3,648|
|Dental Academic|||||||
|Prize|6,500|||||6,500|
|Dental School|||||||
|Prizes|4,618|||||4,618|
|Diabetes Plymouth|||||||
|Fund|24,663|||||24,663|
|Dr Gould Prize|||||||
|fund|73|||(73)|||
|General Restricted|2,158|||||2,158|
|Music Prize|900|||(900)|||
|Peninsula<br>Prize|||||||
|Fund|1,950|||(1,950)|||
||44,510|||(2,923)||41,587|
||At||||Gains and|At|
||1Feb 2021|Income|Expenditure|Transfers|losses|31Jan 2022|
|Just Giving K1,048|||||||
|and Vospers K2,600||8,838|(5,190)|||3,648|
|Brain Tumour|||||||
|Research|4,629||(4,629)||||
|Dental Academic|||||||
|Prize|6,500|||||6,500|
|Dental School|||||||
|Prizes|4,618|||||4,618|
|Diabetes Plymouth|||||||
|Fund|24,663|||||24,663|
|Dr Gould Prize|||||||
|fund|73|||||73|
|General Restricted|2,158|||||2,158|
|Music Prize|900|||||900|
|Peninsula<br>Prize|||||||
|Fund|1,950|||||1,950|
||45,491|8,838|(9,819)|||44,510|





## 

## 

## 

## 

## 

|Tangible fixed an|d current assets creditor|s less than 1year|||
|---|---|---|---|---|
|||Unrestricted|Restricted|Total Funds|
|||Funds|Funds|2022|
|Fixed and current|assets|495,678|41,587|537,265|
|Creditors less than|1 year|(77,602)||(77,602)|
|Net assets||418,076|41,587|459,663|
|||Unrestricted|Restricted|Total Funds|
|||Funds|Funds|2022|
|Fixed and current|assets|624,077|44,510|668,587|
|Creditors less than|1 year|(184,166)||(184,166)|
|Net assets||439,911|44,510|484,421|



## 

##